Clermont Ferrand cedex 01, France Clinical Trials

A listing of Clermont Ferrand cedex 01, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Randomized Trial of 2% Chlorhexidine-70% Isopropanol vs 5% Povidone Iodine-69% Ethanol for Skin Antisepsis in Reducing Surgical-site Infection After Cardiac Surgery

Despite completion of more than 9 million procedures each year in France, the best antiseptic solution to be used for preparing the skin to reduce risk of surgical site infection (SSI) remains unknown. 2% Chlorhexidine gluconate (CHG)-alcohol is superior to Povidone Iodine (PVI)-alcohol for short term vascular catheter care (Mimoz …

University Hospital of Clermont-Ferrand
 (1.9 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +12 other locations
Trial of Andexanet in ICH Patients Receiving an Oral FXa Inhibitor

Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet versus usual standard of care in patients with intracranial hemorrhage anticoagulated with a direct oral anticoagulant

CHU Edouard Herriot, Anaesthesia-resuscitation
 (84.0 away) Contact site
  • 19 views
  • 25 Jan, 2021
  • +133 other locations
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease, diabetes mellitus, or heart failure. Globally, the reported incidence of hyperkalemia varies from 1.1 to 10 per 100 hospitalizations, depending on the patient cohort and comorbidities. Hyperkalemia is a potentially life-threatening electrolyte disturbance that can be fatal …

University Hospital, Grenoble
 (133.6 away) Contact site
  • 1 views
  • 03 Feb, 2021
  • +14 other locations
Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

BK virus nephropathy (BKVN), a consequence of the strong immunosuppressive therapy given after kidney transplantation, represents a growing problem in the kidney transplant (KT) setting. In recent cohorts, BKVN concerns up to 10% of kidney transplant recipients and early signs of BK virus (BKV) infection as development of asymptomatic viruria …

CHU H pital Gabriel Montpied
 (1.6 away) Contact site
  • 18 views
  • 23 Jan, 2021
  • +9 other locations
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by inflammatory arthritis and enthesitis involving the spine. AxSpA prevalence is around 0.17% of the French population. Tumor necrosis factor (TNF) was the first target defined in axSpA. Since one third of axSpA patients failed to the first TNF blocker, many …

monoclonal antibodies
golimumab
steroidal anti-inflammatory drugs
biological therapy
tnf blocker
CH Le Puy en Velay
 (63.5 away) Contact site
  • 17 views
  • 25 Jan, 2021
  • +25 other locations
Cyclosporine A Pretreatment and Kidney Graft Function

Organ donors included in the study are randomized to a control group or an intervention group receiving 2.5 mg/kg of cyclosporine A before organ procurement. Harvested kidneys from these patients are transplanted to chronic kidney insufficiency patients. According to the pretreatment of the transplant, delayed graft function during the first …

cyclosporine
chronic renal insufficiency
delayed graft function
CHU Clermont-Ferrand
 (1.2 away) Contact site
  • 18 views
  • 24 Jan, 2021
  • 1 location
USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)

Phase IV Trial design : Multicentre, randomized, double-blind, placebo-controlled study Population : Moderate to severe Crohn's disease with at least one active perianal fistula track Investigational treatment : Group 1: Ustekinumab (UST) IntraVenous (IV) induction (6mg/kg) followed by UST SubCutaneous (SC) 90mg every 8 weeks. Group 2: Placebo IV followed …

CHU Clermont Ferrand
 (1.6 away) Contact site
  • 0 views
  • 01 Feb, 2021
  • +19 other locations
Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.

Bulimia nervosa (BN) is a serious mental illness characterized by massive food crises followed by anxiety and compensatory behaviours (vomiting more often). Recent data show an increasing prevalence and a serious prognosis, due to excess mortality by suicide but also somatic complications. Two types of treatments are validated : serotoninergic …

positron emission tomography
suicide
vomiting
ssri
bulimia nervosa
Chu Saint-Etienne
 (66.8 away) Contact site
  • 137 views
  • 26 Jan, 2021
  • +3 other locations
Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients

The purpose of this study is to compare the proportion of patients who could withdraw from prednisone and hydrocortisone one year after a progressive decrease of GC (GC tapering) or a hydrocortisone replacement therapy in rheumatoid arthritis in remission or low disease activity.

prednisolone
rheumatic diseases
prednisone
antirheumatics
remission
Saint-Etienne Hospital
 (66.8 away) Contact site
  • 20 views
  • 11 Mar, 2021
  • +16 other locations
Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage

This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be assigned to a 5 weeks regimen with the probiotic (10 9 lactobacillus bid) or to a 5 weeks regimen with placebo.A …

Service des Maladies infectieuses et tropicales
 (1.3 away) Contact site
  • 0 views
  • 07 Nov, 2020
  • 1 location